期刊文献+

盐酸吡格列酮分散片对初发2型糖尿病的疗效观察

下载PDF
导出
摘要 目的:探讨盐酸吡格列酮分散片治疗初发2型糖尿病的疗效。方法:将160例初发2型糖尿病患者随机分为治疗组80例,对照组80例,两组均予以饮食控制、运动治疗、二甲双胍片口服、胰岛素控制血糖及降脂等常规治疗,在此基础上治疗组加服盐酸吡格列酮分散片治疗,观察3个月。治疗前后测定两组空腹血糖、餐后2 h血糖、糖化血红蛋白、血脂、空腹免疫活性胰岛素、体重指数、胰岛素抵抗指数。结果:盐酸吡格列酮分散片具有降糖调脂作用,能改善胰岛功能。结论:盐酸吡格列酮分散片临床降糖调脂作用显著,依从性好,可作为治疗2型糖尿病的一线降糖药物。
作者 王学芳
机构地区 新乡公立医院
出处 《中国民康医学》 2013年第13期70-71,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献5

二级参考文献17

  • 1Julia Tonelli, Weijie Li, Preeti Kishore, et al: Mechanisms of Early Insulin - Sensitizing Effects of Thiazolidinediones in Type 2 Diabetes. Diabetes 2004; 53:1621 - 1629.
  • 2Miyazaki Y, Mahankali A, Matsuda M, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2002 ;2784- 2791.
  • 3Cheng-Lai AM, Levine A. Rosiglitazone: an agent from the thiazolidinedione class for the treatment of type 2 diabetes. Heart Dis 2000 Jul- Aug;2(4) :326 - 333.
  • 4WEerner AL Travaglini MT. A review of rosiglitazone in type 2 diabetes mellitus. Pharmacotherapy 2001 Sep;21(9): 1082 - 99.
  • 5Gillies PS, Dunn CJ.: Pioglitazone. Drugs 2000 Aug; 60 (2):333 - 343.
  • 6Hanefeld M, Belcher G. Safety profile of pioglitazone. Int J Clin Pract Suppl 2001 Sep; (121) :27- 31.
  • 7Hanefeld M. Pharmacokinetics and clinical efficacy of pioglitazone. Int J Clin Pract Suppl 2001 Sep; (121): 19 - 25.
  • 8Nakamura T, Ushiyama C, Osada S, et al. Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. Metabolism 2001 Oct; 50(10): 1193 - 6.
  • 9Smith U. Pioglitazone: mechanism of action Int J Clin Pract Suppl 2001 Sep; (121): 13 - 18.
  • 10The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 1997,20:1183-1197.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部